I will be giving a pair of talks on biotechnology commercialization at the University of Texas at Arlington on November […]
Discussing Biotechnology Commercialization at UT Arlington Read Post »
Approved Drug Products With Therapeutic Equivalance Evaluations In addition to its deep database of global drug and patent information, DrugPatentWatch
I have a tool that can be used to measure the impact of Brexit on biotechnology in the United Kingdom.
The following paper has been added to the free open access archives at the Journal of Commercial Biotechnology: Using Biotechnology,
Journal of Commercial Biotechnology Labels, Lawyers, & Logic Peter J. Pitts America deserves access to high-quality health care without avoidable
Journal of Commercial Biotechnology New Issue Published Read Post »
My paper on global biopharmaceutical productivity has been published in the latest issue of Nature Biotechnology. This paper is a
The nature of Asian biopharmaceutical innovation Read Post »
The back-issues of the Journal of Commercial Biotechnology more than five years old are now free. For complete access, see
Journal of Commercial Biotechnology Free Archives Read Post »
Six years ago I built a global biotechnology innovation index, and I have been using it since tracking global biotechnology
Tracking global biotechnology innovation for a sixth year Read Post »
The Journal of Commercial Biotechnology announces the publication of the July 2013 issue, featuring new papers on biotechnology management and
Journal of Commercial Biotechnology July 2013 issue now available Read Post »
Journal of Commercial Biotechnology Vol 19, Issue 2 (2013) Capturing Value G. Steven Burrill Today’s pressure on pharmaceutical companies reflects